Kiat Ruxrungtham
Overview
Explore the profile of Kiat Ruxrungtham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
291
Citations
4388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pongma C, Keawvilai P, Boonmee A, Wongprom B, Pattarakankul T, Sittplangkoon C, et al.
Sci Rep
. 2025 Jan;
15(1):1146.
PMID: 39774150
Delivery of an mRNA formulated with lipid nanoparticles (LNPs) induces robust humoral and cell-mediated branches of the immune response. Depending on the LNP formula, mRNA encoding proteins can be detected...
2.
Kanjanawasee D, Poachanukoon O, Sriprasart T, Chirakalwasan N, Saiphoklang N, Athipongarporn A, et al.
Asian Pac J Allergy Immunol
. 2025 Jan;
42(4):318-332.
PMID: 39756066
This part reviews the management of chronic cough and proposes a management algorithm. Despite proven improvements in quality of life following chronic cough treatment, a clear understanding of the disease...
3.
Kanjanawasee D, Poachanukoon O, Sriprasart T, Chirakalwasan N, Saiphoklang N, Athipongarporn A, et al.
Asian Pac J Allergy Immunol
. 2025 Jan;
42(4):305-317.
PMID: 39756065
Chronic cough is a common clinical condition requiring comprehensive assessment. This review employs a symptom-focused approach, prioritizing the presenting symptom of "chronic cough" to mirror real-world clinical practice. Ten key...
4.
Suratannon N, Limsuwan T, Tantilipikorn P, Chatchatee P, Saengapaswiriya A, Boonpiyathad T, et al.
Asian Pac J Allergy Immunol
. 2024 Oct;
42(3):233-245.
PMID: 39417769
Background: Previous house dust mite subcutaneous immunotherapy (HDM SCIT) placebo-controlled trials have small sample sizes and lack a consensus on baseline treatment. Objective: To determine the efficacy of HDM SCIT...
5.
Prompetchara E, Ketloy C, Khawsang C, Palaga T, Ruxrungtham K
Asian Pac J Allergy Immunol
. 2024 Oct;
42(3):191-206.
PMID: 39417768
Mpox is currently a global health emergency. This review (Part II) aims to provide insights into Mpox vaccines and their advancements, offering easily digestible information for healthcare workers and researchers....
6.
Prompetchara E, Ketloy C, Khawsang C, Ruxrungtham K, Palaga T
Asian Pac J Allergy Immunol
. 2024 Oct;
42(3):181-190.
PMID: 39417767
Mpox, the zoonotic disease caused by Monkeypox virus (MPXV), is currently a global health emergency. This review (Part I) aims to provide insights into the virus life cycle, epidemiology, host...
7.
Deenin W, Khongchareonporn N, Ruxrungtham K, Ketloy C, Hirankarn N, Wangkanont K, et al.
Anal Chem
. 2024 Mar;
96(14):5407-5415.
PMID: 38478766
COVID-19 vaccines have been provided to the general public to build immunity since the 2019 coronavirus pandemic. Once vaccinated, SARS-CoV-2 neutralizing antibodies (NAbs-COVID-19) are needed for excellent protection against COVID-19....
8.
Puthanakit T, Prompetchara E, Gatechompol S, Ketloy C, Thitithanyanont A, Jongkaewwattana A, et al.
Sci Rep
. 2024 Jan;
14(1):2373.
PMID: 38287068
ChulaCov19 mRNA vaccine demonstrated promising phase 1 results. Healthy adults aged 18-59 years were double-blind randomised 4:1 to receive two intramuscular doses of ChulaCov19 50 µg or placebo. Primary endpoints...
9.
Sudsila P, Teeraananchai S, Kiertiburanakul S, Lertpiriyasuwat C, Triamwichanon R, Gatechompol S, et al.
J Int Assoc Provid AIDS Care
. 2023 Dec;
22:23259582231220513.
PMID: 38115729
This study aimed to assess second-line antiretroviral therapy (ART) outcomes in a National HIV Treatment program. People living with HIV aged ≥18 years initiating first-line ART who switched to second-line...
10.
Phoka T, Thanuthanakhun N, Visitchanakun P, Dueanphen N, Wanichwecharungruang N, Leelahavanichkul A, et al.
Vaccine X
. 2023 Nov;
15:100398.
PMID: 37920235
Although vaccine administration by microneedles has been demonstrated, delivery reliability issues have prevented their implementation. Through an porcine skin experiment, we show visual evidence indicating that detachable dissolvable microneedles (DDMN)...